Effect of Somatostatin Receptor 2 Antagonism (SSTR2a) on Oral Glucose Tolerance (OGT) in a Rat Model of Type 2 Diabetes (T2D)

被引：0
|
作者：
D'Souza, Ninoschka C.
Aleali, Nadia
Shakeri, Dorsa
Hoffman, Emily G.
Atherley, Sara C.
Champsi, Sabrina
El-Zahed, Maya
Liggins, Richard
Chan, Owen
Riddell, Michael C.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-2-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of Somatostatin Receptor 2 Antagonist (SSTR2a) on Glycemia and Glucagon Levels in a Rat Model of Type 2 Diabetes (T2D)
    D'Souza, Ninoschka C.
    Hoffman, Emily G.
    Atherley, Sara C.
    Champsi, Sabrina
    Popkov, Mariya
    Liggins, Richard
    Riddell, Michael
    DIABETES, 2021, 70
  • [2] Effects of Sustained Somatostatin Receptor 2 Antagonism (SSTR2a) on Glycemia in Type 2 Diabetic (T2D) Male Rats-A Pilot Study
    Aleali, Nadia
    D'Souza, Ninoschka C.
    Shakeri, Dorsa
    Simonson, Eric
    Liggins, Richard
    Chan, Owen
    Riddell, Michael C.
    DIABETES, 2023, 72
  • [3] Somatostatin Receptor Type 2 Antagonism (SSTR2a) Augments Glucagon Counterregulation and Delays Hypoglycemia Onset in Type 2 Diabetic (T2D), Sprague-Dawley Rats
    Hoffman, Emily G.
    Dsouza, Ninoschka
    Aiken, Julian
    Liggins, Richard
    Riddell, Michael
    DIABETES, 2021, 70
  • [4] Impact of SSTR2a Treatment in Hypoglycemia in Male (M) and Female (F) Rat Models of Type 2 Diabetes (T2D)
    Dsouza, Ninoschka
    Aleali, Nadia
    Shakeri, Dorsa
    Atherley, Sara C.
    Hoffman, Emily G.
    Karimi-Chahartash, Sina
    Javanbakhsh, Sahel
    Chan, Owen
    Liggins, Richard
    Riddell, Michael C.
    DIABETES, 2024, 73
  • [5] Evaluating the Effectiveness of the Novel Somatostatin Receptor Antagonist (SSTR2a) ZT-01 for Hypoglycemia Prevention in a Rodent Model of Type 2 Diabetes
    D'Souza, Ninoschka C.
    Aiken, Julian
    Atherley, Sara C.
    Champsi, Sabrina
    Aleali, Nadia
    Shakeri, Dorsa
    El-Zahed, Maya
    Akbarian, Nicky
    Nejad-Mansouri, Mehran
    Liggins, Richard
    Chan, Owen
    Riddell, Michael C.
    Bavani, Parinaz Zaree
    DIABETES, 2023, 72
  • [6] Somatostatin Receptor Subtype 2 A (SSTR2A) and HER2 Expression in Gastric Adenocarcinoma
    Romiti, Adriana
    Di Rocco, Roberta
    Milione, Massimo
    Ruco, Luigi
    Ziparo, Vincenzo
    Zullo, Angelo
    Duranti, Enrico
    Sarcina, Ida
    Barucca, Viola
    D'Antonio, Chiara
    Marchetti, Paolo
    ANTICANCER RESEARCH, 2012, 32 (01) : 115 - 119
  • [7] Somatostatin receptor type 2A (SSTR2A) is expressed in pineal parenchyma and in tumours derived from it
    Hans, V. H.
    Oppel, F.
    Neubauer, U.
    Bergmann, M.
    ACTA NEUROPATHOLOGICA, 2008, 116 (03) : 345 - 345
  • [8] The Glucagon Stimulating Effect in Hypoglycemia of Somatostatin Receptor 2 Antagonist (SSTR2a) Is Maintained with Repeat Dosing
    Dsouza, Ninoschka
    Aleali, Nadia
    Shakeri, Dorsa
    Atherley, Sara C.
    Hoffman, Emily G.
    Karimi-Chahartash, Sina
    Javanbakhsh, Sahel
    Chan, Owen
    Liggins, Richard
    Riddell, Michael C.
    DIABETES, 2024, 73
  • [9] Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer
    Terlevic, Robert
    Balja, Melita Peric
    Tomas, Davor
    Skenderi, Faruk
    Kruslin, Bozo
    Vranic, Semir
    Demirovic, Alma
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2019, 38 : 62 - 66
  • [10] Mesenteric Visceral Lipectomy (MVL) Improves Glucose Tolerance in Patients with Type 2 Diabetes (T2D)
    Baskoy, Gozde
    Peterson, Richard M.
    Kempenich, Jason W.
    Triplitt, Curtis L.
    Clarke, Geoffrey D.
    Cersosimo, Eugenio
    Andrew, Mark S.
    Merovci, Aurora
    Lavrynenko, Olga
    Hansis-Diarte, Andrea A.
    Solis-Herrera, Carolina
    Chavez, Alberto
    Salehi, Marzieh
    Defronzo, Ralph A.
    DIABETES, 2024, 73
12345